- Home
- BEDU vs PRLD Comparison
BEDU vs PRLD Comparison
Compare BEDU & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- PRLD
- Stock Information
- Founded
- BEDU 1994
- PRLD 2016
- Country
- BEDU United Kingdom
- PRLD United States
- Employees
- BEDU N/A
- PRLD N/A
- Industry
- BEDU Other Consumer Services
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- BEDU Real Estate
- PRLD Health Care
- Exchange
- BEDU Nasdaq
- PRLD Nasdaq
- Market Cap
- BEDU 54.3M
- PRLD 44.0M
- IPO Year
- BEDU 2017
- PRLD 2020
- Fundamental
- Price
- BEDU $1.83
- PRLD $1.11
- Analyst Decision
- BEDU
- PRLD Strong Buy
- Analyst Count
- BEDU 0
- PRLD 3
- Target Price
- BEDU N/A
- PRLD $4.00
- AVG Volume (30 Days)
- BEDU 4.6K
- PRLD 222.3K
- Earning Date
- BEDU 11-25-2025
- PRLD 11-05-2025
- Dividend Yield
- BEDU N/A
- PRLD N/A
- EPS Growth
- BEDU N/A
- PRLD N/A
- EPS
- BEDU N/A
- PRLD N/A
- Revenue
- BEDU $224,321,752.00
- PRLD $7,000,000.00
- Revenue This Year
- BEDU N/A
- PRLD N/A
- Revenue Next Year
- BEDU N/A
- PRLD N/A
- P/E Ratio
- BEDU N/A
- PRLD N/A
- Revenue Growth
- BEDU N/A
- PRLD N/A
- 52 Week Low
- BEDU $1.35
- PRLD $0.61
- 52 Week High
- BEDU $2.19
- PRLD $2.84
- Technical
- Relative Strength Index (RSI)
- BEDU 57.26
- PRLD 50.40
- Support Level
- BEDU $1.57
- PRLD $1.10
- Resistance Level
- BEDU $1.71
- PRLD $1.26
- Average True Range (ATR)
- BEDU 0.07
- PRLD 0.12
- MACD
- BEDU 0.00
- PRLD -0.02
- Stochastic Oscillator
- BEDU 76.69
- PRLD 4.35
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.